Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyMargaret A. Tempero, Giby V. George|Journal of the National Comprehensive Cancer Network|2021Cited by 1.3k
Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic CancerTakahiro Tsujikawa, Dung T. Le, Jennifer N. Durham et al.|Clinical Cancer Research|2020Cited by 151
Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE studyMargaret A. Tempero, Teresa Macarulla|Annals of Oncology|2021Cited by 113